Characteristic | GI symptoms (n=74) | No GI symptoms (n=577) | P value |
Age | 46.14±14.19 | 45.09±14.45 | 0.559 |
Sex (male) | 37/74 (50.0%) | 294/577 (50.95%) | 0.902 |
Current smoker | 3/74 (4.23%) | 38/577 (6.59%) | 0.610 |
Pre-existing conditions | |||
Any | 25/74 (33.78%) | 153/577 (26.52%) | 0.212 |
Hypertension | 12/74 (16.22%) | 88/577 (15.25%) | 0.864 |
Diabetes | 7/74 (9.46%) | 41/577 (7.11%) | 0.477 |
Chronic liver disease | 8/74 (10.81%) | 17/577 (2.95%) | 0.004 |
Cancer | 0/74 (0%) | 6/577 (1.04%) | 1.00 |
Chronic renal disease | 0/74 (0%) | 6/577 (1.04%) | 1.00 |
Heart disease | 1/74 (1.35%) | 4/577 (0.69%) | 0.454 |
Pregnancy | 0/74 (0%) | 3/577 (0.52%) | 1.00 |
COPD | 0/74 (0%) | 1/577 (0.17%) | 1.00 |
Immunosuppression | 0/74 (0%) | 1/577 (0.17%) | 1.00 |
Exposure history | |||
From Wuhan | 38/74 (51.35%) | 347/577 (60.14%) | 0.167 |
Contact with patients | 32/74 (43.24%) | 230/577 (39.86%) | 0.615 |
Family cluster | 23/74 (31.08%) | 118/577 (20.45%) | 0.037 |
Clinical type on admission | |||
Severe/Critical type (%) | 17/74 (22.97%) | 47/577 (8.14%) | <0.001 |
Data are presented as medians (IQR), n (%) and n/N (%).
COPD, chronic obstructive pulmonary disease.